- Home
- BLCO vs PHI Comparison
BLCO vs PHI Comparison
Compare BLCO & PHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- PHI
- Stock Information
- Founded
- BLCO 1853
- PHI 1928
- Country
- BLCO Canada
- PHI Philippines
- Employees
- BLCO N/A
- PHI N/A
- Industry
- BLCO Ophthalmic Goods
- PHI Telecommunications Equipment
- Sector
- BLCO Health Care
- PHI Telecommunications
- Exchange
- BLCO Nasdaq
- PHI Nasdaq
- Market Cap
- BLCO 4.4B
- PHI 4.8B
- IPO Year
- BLCO 2022
- PHI 1953
- Fundamental
- Price
- BLCO $11.70
- PHI $21.68
- Analyst Decision
- BLCO Hold
- PHI
- Analyst Count
- BLCO 13
- PHI 0
- Target Price
- BLCO $15.63
- PHI N/A
- AVG Volume (30 Days)
- BLCO 578.9K
- PHI 58.3K
- Earning Date
- BLCO 07-30-2025
- PHI 08-12-2025
- Dividend Yield
- BLCO N/A
- PHI 7.88%
- EPS Growth
- BLCO N/A
- PHI 14.93
- EPS
- BLCO N/A
- PHI 2.54
- Revenue
- BLCO $4,829,000,000.00
- PHI $3,804,539,911.00
- Revenue This Year
- BLCO $6.97
- PHI $3.85
- Revenue Next Year
- BLCO $5.48
- PHI $2.33
- P/E Ratio
- BLCO N/A
- PHI $8.44
- Revenue Growth
- BLCO 11.94
- PHI 2.38
- 52 Week Low
- BLCO $10.45
- PHI $20.29
- 52 Week High
- BLCO $21.69
- PHI $29.05
- Technical
- Relative Strength Index (RSI)
- BLCO 45.65
- PHI 37.30
- Support Level
- BLCO $11.44
- PHI $21.48
- Resistance Level
- BLCO $12.70
- PHI $22.09
- Average True Range (ATR)
- BLCO 0.36
- PHI 0.37
- MACD
- BLCO 0.01
- PHI -0.07
- Stochastic Oscillator
- BLCO 30.07
- PHI 12.90
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About PHI PLDT Inc. Sponsored ADR
PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.